Skip to content
Navigation
- Introduction to Orthopedic Medical Devices and orthopedic company
- Stryker: $13.6 billion in revenue in 2018
- Johnson & Johnson Orthopedics: $8.9 billion in revenue in 2018
- Zimmer Biomet: 7.9 billion in revenue in 2018
- Smith & Nephew: 2018 Revenue: $3.629 billion
- Medtronic-Spine Business: Recent Acquisition and Growth. $2.7 billion in revenue in 2018
Introduction to Orthopedic Medical Devices and orthopedic company
Orthopedic medical devices are one of the largest subsectors within the medical device industry. The implants of orthopedic are the most important ones. Due to their high value, significant impact on human life and health, and strict control over production and use, orthopedic implants are generally classified as high-value medical consumables. As one of the most important fields of high-value consumables, orthopedics has always been a must for global medical giants. However, the global growth rate of orthopedic companies is relatively sluggish compared with other medical fields (IVD, cardiovascular, medical imaging, etc.).
In the environment where the giants have been getting most of the resources for many years, there are fewer and fewer targets available for acquisition. How to achieve sustainable growth? It has become a trend to shift acquisition targets to large enterprises at the top of the food chain. Today we will evaluate and rank all orthopedic companies. The ranking has stayed the same for many years and has changed like a reshaping structure with the deepening of business restructuring.
The world’s well-known orthopedic implant manufacturers, who are they? How much do they profit, and their market share?
We list the top 5 orthopedic companies in the world. It shows that Stryker won the No. 1 title in the global orthopedic market with a revenue of US$13.6 billion. Johnson & Johnson-DePuy Synthe’s orthopedic business with a revenue of US$8.9 billion, came in second. The third is Zimmer Biomet, and the fourth is Smith & Nephew, while Medtronic ranks fifth.
Stryker: $13.6 billion in revenue in 2018
Stryker became the world’s largest orthopedic company in 2018, with solid revenue momentum and sales growth of approximately 9.3%, reaching about US$13.6 billion. Stryker’s profit in 2018 more than doubled to about $3.6 billion.
Stryker said that K2M (a wholly-owned subsidiary by Stryker), which was acquired for $1.4 billion in November 2018, has consolidated its position in the spinal treatment market. And expects double-digit growth in 2019 for its MaKo system for robotic implant knee and hip surgery. At the American Academy of Orthopedic Surgeons (AAOS), Stryker called the MaKo system the best system in its growing classStryker said that K2M, acquired for $1.4 billion in November 2018, has consolidated its position in the spinal treatment market. It expects double-digit growth in 2019 for its MaKo system for robotic implant knee and hip surgery. At the American Academy of Orthopedic Surgeons (AAOS), Stryker called the MaKo system the best in its growing class.
In addition, Stryker will continue to invest in technological innovation. In March, it announced the acquisition of OrthoSpace, an Israeli orthopedic medical device company, for US$220 million and obtained its flagship product InSpace, which can be used to treat patients with difficult-to-treat rotator cuff tears and as an Alternative to internal flipping.
Johnson & Johnson Orthopedics: $8.9 billion in revenue in 2018
According to its annual report, J&J’s orthopedic equipment sales fell 1.9 percent in 2018 to $8.9 billion. In 2017, Johnson & Johnson sold its Codman neurosurgery business (spinal cord and cranial repair product manufacturer) to Integra Life Sciences for more than $1 billion, making Johnson & Johnson DePuy Synthes negative growth since 2017. In addition, sales of Johnson & Johnson’s knee surgery products also declined due to competitive pressure in the US market.
In 2018, J&J launched new products related to the hip and spine, including the Concorde Lift expandable device and the Viper Prime system for minimally invasive procedures. Johnson & Johnson is also developing a robot-assisted orthopedic surgery platform after acquiring French robot-assisted surgery company Orthotaxy in 2018. It is reported that the Orthotaxy robot is smaller than current surgical robots.
Zimmer Biomet: 7.9 billion in revenue in 2018
In 2018, Zimmer Biomet’s revenue was US$7.93 billion, and it is undergoing a two-year restructuring plan. It received some critical clearances from government regulators in 2018, such as its approval in October 2018 for a personal remodeling knee implant with custom components to match each patient’s anatomy in early 2019, the company’s Rosa Knee robot-assisted total knee replacement surgery platform was approved, followed by the Rosa One robotic spine system.
It is worth noting that at the end of 2018, Zimmer Biomet suffered losses caused by judicial litigation. It lost the patent case against Stryker’s surgical tools and compensated 248 million US dollars. Chief executive Brian Hansen said: “Overall, our full-year financial results align with our expectations for the progress of our business transformation, increasing our confidence in achieving our 2019 goals.”
Smith & Nephew: 2018 Revenue: $3.629 billion
In 2018, the company’s knee implant business grew by 3% to more than $1 billion, and its hip implant business grew by 2% to $613 million. The company demonstrated Navio 7.0, the latest software for its handheld robotic surgery system in 2018, the company’s knee implant business grew by 3% to more than $1 billion, and its hip implant business grew by 2% to $613 million. The company demonstrated Navio 7.0, the latest software for its handheld robotic surgery system, at the AAOS conference last month, which is expected to be released in the second half of this year. at the AAOS conference last month, which is expected to be released in the second half of this year.
Medtronic-Spine Business: Recent Acquisition and Growth. $2.7 billion in revenue in 2018
In 2018, Medtronic’s spine business had a revenue of approximately $2.7 billion. In December 2018, Medtronic completed the $1.7 billion acquisition of Mazor Robotics and its robot-assisted spine surgery platform. At that time, some analysts said that the acquisition of Mazor Robotics would undoubtedly greatly strengthen Medtronic’s strength in the field of spinal surgery assistance. A month after the acquisition closed, Medtronic launched the Mazor X Stealth robot-assisted spinal surgery platform in the United States. Medtronic executives expect Mazor X Stealth will help Medtronic expand its neurosurgery business and create demand for spinal implants.